chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pregnancy at time of Vaccination: Yes; Injection site pain, heavy feeling in the arm, chest pain, fluid retention feeling in the area; Injection site pain, heavy feeling in the arm, chest pain, fluid retention feeling in the area; Injection site pain, heavy feeling in the arm, chest pain, fluid retention feeling in the area; Injection site pain, heavy feeling in the arm, chest pain, fluid retention feeling in the area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38 year-old female patient (pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 20May2021 (Lot number: Ew0182) at the age of 38 years as dose 1, single and administration date 20May2021 (Lot number: Ew0217) for covid-19 immunisation. The patient had no relevant medical history. Date of last menstrual period: 05Oct2020. The patient was 32 weeks pregnant at the time of exposure to bnt162b2. The patient was 43 weeks pregnant at the event onset. The patient is expected to deliver a baby(s) on 06Jul2021. The patient's concomitant medications were not reported. The following information was reported: EXPOSURE DURING PREGNANCY (non-serious) with onset 03Aug2021 10:00, outcome "not recovered", described as "Pregnancy at time of Vaccination: Yes"; VACCINATION SITE PAIN (non-serious), LIMB DISCOMFORT (non-serious), CHEST PAIN (non-serious), FLUID RETENTION (non-serious) all with onset 03Aug2021 10:00, outcome "not recovered" and all described as "Injection site pain, heavy feeling in the arm, chest pain, fluid retention feeling in the area". Therapeutic measures were not taken as a result of exposure during pregnancy, vaccination site pain, limb discomfort, chest pain, fluid retention.  Additional Information: Reporter was reported that No any other vaccine was taken in four weeks and no other medication was taken in 2 weeks. No covid was reported prior to vaccination. It was also No if covid was tested positive post the vaccination. No known allergies and other medication history was reported.  No follow-up attempts are possible. No further information is expected.
Low blood pressure starting approximately 15-17 hrs hours after vaccination, continuation of symptoms at least 3 days after vaccination. It was challenging to stand on my own, extreme light-headedness, blood pressure wasn't taken until March 6th. The symptoms were the worst on March 4th, they improved over the past day or so, however when taking blood pressure reading on March 6th, 2021, blood pressure was 110/60 at 8 am, so it is highly indicative that blood pressure was even lower in the previous days. Other accompanying symptoms on 3/4 were headache, low fever, fatigue, sore arm, achiness (expected side effects). Other side effects on 3/5 were nausea and metallic taste (expected side effects). There were no swelling of throat or breathing problems.
This spontaneous report as received from a physician and refers to an unspecified number of patients of unknown age and gender. Medical history and concomitant medications were unknown. It was reported that improperly stored doses of PEDVAXHIB lot # L002867 expiration date 11-NOV-2017, and lot # L014426 expiration date 08-MAR-2018, (dose and route were not reported), were given to unspecified patients on unspecified dates. No adverse  effects were reported. It was unknown if the patients sought medical attention. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
CAD Incident No. 2021-00018948 "Moderna COVID 19 Vaccine EUA" Patient received his first dose of Moderna vaccine then proceded to the observation area. Shortly therafter he told the EMT that he waas stating to feel dizzy and lightheaded. Two Paramedics at the patient side. Advise the Patient that we would like to lay him down. Patient then went Flaccid and limp, aasststed to the ground, no trauma. Patient started to answer assessment questions after 15-20 seconds of laying in the supine postion. Full Assessment, No signs of Allergic reaction. Patient Sign out AMA on EPCR via Tablet. Base hospital was contacted for AMA radio report. See EPCR for any further details and Vital signs.
Injection site itching; Vaccination site rash; injection site redness; Respiratory issue; This spontaneous case was reported by a consumer and describes the occurrence of RESPIRATORY DISORDER (Respiratory issue), VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (injection site redness) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. C21A) for COVID-19 vaccination.     Medical history was not provided by the reporter.  Concomitant products included FLUCONAZOLE for Antifungal treatment.   On 13-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In May 2021, the patient experienced RESPIRATORY DISORDER (Respiratory issue). On 17-May-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (injection site redness). In May 2021, RESPIRATORY DISORDER (Respiratory issue) had resolved. At the time of the report, VACCINATION SITE PRURITUS (Injection site itching), VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (injection site redness) outcome was unknown.            Patient has not taken any medication for the symptoms.  Action taken with mRNA-1273 in response to the events was not applicable.
Information has been received from a registered nurse referring to an unspecified number of patients of unknown age and gender. On unspecified dates the patients were vaccinated with doses of improperly stored RECOMBIVAX HB (strength, dosage, frequency and route unspecified) lot # J012567 with expiration date 30-JAN-2016 since the initial temperature excursion on 15-OCT-2014. The temperature excursion for RECOMBIVAX HB was unsupported with in-house stability data. No adverse event was reported. This is one of several reports received from the same reporter. Additional information has been requested.
recv vax 05dec96; fever & rash devel 12dec96; 15dec96 sz
Infs split virus; Initial information received on 13-Sep-2021 regarding an unsolicited valid  non-serious case received from a consumer or non- healthcare professional (hcp).  This case involves female patient (age not reported) who experienced infs (influenza) split virus when received vaccine INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE [FLUZONE].  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On 30-Nov-2010, the patient received a dose of suspect INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE (lot number: UH214AB and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On 30-NOV-2010 the patient developed a non-serious infs (influenza) split virus (influenza) same day following the administration of INFLUENZA USP TRIVAL A-B SUBVIRION VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment for the event [Infs (influenza) split virus].  The event outcome was unknown for influenza.; Sender's Comments:  00766451:
About 10 minutes after receiving the first shot of COVID-19 (PFIZER), patient fainted and fell to the floor from the chair he was sitting on. He gained consciousness within seconds and was responsive. Patient reported feeling dizzy but no signs of trouble breathing or any other symptoms. EMS arrived shortly and assessed the patient. According to the EMS, patient's vitals were all normal and patient refused to go to the hospital with them because he was feeling fine.
This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 12-SEP-2017, the patient was inadvertently vaccinated with expired dose of GARDASIL 9 lot # L028083 with expiration date: 03-SEP-2017 (dose and route of administration were not reported). No adverse effect was reported. Product quality complaint was not involved.
On 07/14/2001 at 5AM the patient developed hives and itching on her left and right forearms. On 07/14/2001 at 4PM the patient's hands were swollen, the hives and itching had spread to her hands and feet and she experienced chills. The patient was treated with Deaconess, Nashoba and Benadryl.
Symptoms began a few days after I received the 2nd shot. Headaches, face and teeth throbbing most of the time, pressure from eyes and forehead trying to push back into my head, frequent periods when it feels like my brain is inflamed and paralyzed. These symptoms change throughout each day but some are always present. And I never feel like I can fully wake up, like I'm only 2/3 awake when I'm at my best.
Information has been received from a medical assistant concerning a patient who on May 2007, was vaccinated with the first dose of VAQTA pediatric. The patient would receive the booster dose on 26-JAN-2010. No adverse effects were reported. Follow up information has been received from a certified medical assistant concerning a 4 year old male with milk, egg, soy and PRELONE allergies, who was vaccinated with a dose of VAQTA (lot # 665167/0913Y) (the patient did not received VAQTA in May 2007 or on 26-JAN-2010 as previously reported). The patient received a dose of DTaP in May 2007. A few minutes after VAQTA vaccination, at 9:00 AM on 11-NOV-2009 the patient broke out in a rash and hives. The patient had visited the doctor. BENADRYL was given in the office and the child quickly recovered. There were no serious criteria. No further information is available.
Large bulge under my armpit looks like an extremely enlarged lymph node along with sore and constant throbbing pain up to my neck, I have limited range of motion and can?t properly keep my arm in normal position because of the pain and swelling
Left upper arm and armpit swelling with discomfort which occurred on day 4 post vaccines. Area swollen but no redness/hardness/drainage/fever reported. Presented to Urgent Care and was prescribed ZITHROMAX and ADVIL.
I received 2nd dose of Moderna vaccine on 01/25/2021 at 10:30am The afternoon after the 2nd dose I got a headache. Approximately 12 hours after vaccine I had severe body aches,chills, a fever of 102, & fatigue. These symptoms lasted a little more than 24 hours except for the fatigue which lasted about 3 days. I took Tylenol for body aches and fever.
Chest tightness and pain as well as shortness of breath. Started mid day two after being vaccinated
just been feeling off; headache; tightness in lungs; loose stool; This is a spontaneous report from a contactable health care professional (patient). A 47-year-old non-pregnant female patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration, administered in the right arm on 03Mar2021 at 15:00 (Lot Number: EN6202) as dose 1, single for COVID-19 immunization.  Medical history Hashimotos, Polyarthritis (most likely psoriatic) and allergies to sulfa antibiotics, penicillin (reported as PCN), scallops and gluten all from unknown dates. The patient did not have COVID prior to vaccination. The patient was not tested for COVID post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID); liothyronine sodium (CYTOMEL); trazodone (manufacturer unknown); etanercept (ENBREL) and semaglutide (OZEMPIC), all taken for an unspecified indication, start and stop date were not reported. The patient experienced headache, tightness in lungs, loose stool and has just been feeling off on 04Mar2021 at 07:15. The patient did not receive treatment for the events. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Terrible knot, bruise, and branches of broken blood vessels on back of arm. Much pain. Couldn't move arm for 7-10 days. Due to their negligence, pt was given way to many shots. They failed to rcord some of her previous shots on their records. Has been fixed on their now, but to late.  By age 4, pt was given way to many shots due to negligence. Here is the list of all of her shots: DTaP 5 doses, Hep A 2 doses, Hep B 2 doses, Hep B- Hib 2 doses,  Hib- Hboc 3 doses, Hib Covax 1 dose ( still not recorded by health dept), IPV 4 doses, MMR 3 doses, Varicella 2 doses. All were valid doses given at appropriate times.
Right arm red, swollen, hot to touch c/o itching area swollen is 5"x3", Temp 99.7 yesterday 10/18/2006.
This spontaneous report was received from a nurse practitioner and refers to a patient of unknown age and gender. On an unknown date, the patient was vaccinated with the first dose of VARIVAX, dose, route and frequency unknown. On 14-MAR-2012, the patient was vaccinated with improperly stored VARIVAX lot # 0931AA, dose number 2. No adverse effects were reported. This is one of several reports received from the same source. Additional information has been requested.
Fever > 100 degrees.  Vesicular lesion all over body including scalp and ear canal in varying stages of development.  Diagnosis: Varicella; Treatment: Acyclovir
Headache, Myalgia, Arthralgia, NauseaVomiting, tired Narrative:
I unexpectedly started my menstrual period about 8-10 hours after I received the first dose of vaccine.  I received the second dose of vaccine on 7/16/2021 without any unusual side effects. About 3 months later (October 2021), I started my menstrual period again and it lasted for 7 weeks with heavy bleeding and blood clots. However, I do want to note that I gave birth in the fall of 2020 and my period has not been consistent since that time.  The unusual symptoms that I am experiencing with my irregular periods may be associated with the vaccine, being postpartum, or a combination of both.
Initial report received on 18 November 2011 from the Investigator participating in a study under the reference number M5A16. A case of pertussis disease in an 8-month-old male subject was identified by the investigator based on review of data from the Electronic Disease Surveillance System (EDSS) electronic database. The subject's vaccine history included 3 doses of PENTACEL; lot number C3758AA received on 03 March 2011, lot number C3806A received on 12 May 2011 and lot number C3852AA received on 07 July 2011 (route and site of administration not reported). The subject developed cold-like symptoms on 26 September 2011, approximately 11 weeks after the last dose. On 06 October 2011, the subject developed a paroxysmal cough without a whoop and post-tussive vomiting. The subject also experienced sleep disturbance. Laboratory testing included positive PCR on 06 October 2011. Chest x-ray findings were negative for pneumonia. Corrective treatments consisted of azithromycin starting on 07 October 2011 for 5 days. The subject was not hospitalized. At the time of final contact on 24 October 2011, the subject's cough had resolved. The duration of the cough was reported at that time as 35 days. Documents held by sender: None.
About after 10 mins of the shot, Pt was in lobby being monitored for the adverse reaction. She started having burning pain in the whole left arm, Sweat and Chills, she felt something stuck in the throat and medicine taste in her mouth. Called EMS, Paramedics evaluated and said, she can go home and watch for the symptoms.
My period started two weeks early. This was already strange because my periods are very regular. I was bleeding very heavily; My period started two weeks early. This was already strange because my periods are very regular.; lightheaded; My period started two weeks early. This was already strange because my periods are very regular. I was bleeding very heavilynoticed several blood clots; This is a spontaneous report from a contactable consume (patient). A 22-years-old non pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 07Apr2021 (at the age of 22 years old) (Batch/Lot Number: ER8734) as SINGLE DOSE for covid-19 immunisation. The patients medical history and  concomitant medications were not reported. No other vaccines were given within 4 weeks. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 20Apr2021 the patient experienced  period started two weeks early, bleeding very heavily (medically significant), noticed several blood clots as well and lightheaded. The clinical course was reported as follows ' My period started two weeks early. This was already strange because my periods are very regular. I was bleeding very heavily and I considered going to urgent care but I was light headed and decided against driving. I noticed several blood clots as well. No Treatment was given for the events. The clinical outcome of the events was recovered. The patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), Single dose, Lot number EW0170 on 28Apr2021     No follow-up attempts are needed. No further information is expected.
31 yo male presents with swelling, redness, pain, and itching to R upper arm x 2 days. 3 days ago received 6th Anthrax vaccination. Sx external from mild upper arm to proximal forearm measuring 29x21 cm.
On 12-2-18, Patient called Pharmacist to say she had a bad reaction to the vaccine. She said a few hours after vaccination she became very ill. She experienced chills and felt hot. She then went to bed. Next morning she was better.
Patient has swelling  at the injection site.  Redness of entire arm and  slight pain with swelling
9/29/2023 Given 0.5 mL  IM RD   GlaxoSmithKline 9CE79  Exp. Date NDC # Product Time Location External Inventory Class 6/30/2024 58160-909-41 Fluarix Quad 2023-2024 (PF) 10:16 AM  Comment: VIS offered and attached to AVS; pt. tolerated well
Patient fainted following administration of ZOSTAVAX immunization. Patient never stopped breathing and seemed to recover after a few minutes. Pt was taken to Emergency Room by ambulance for follow up.
Arthralgia Narrative: Joint pain for 2 days. Pain then resoled. 3 weeks later developed bilateral hip pain. Usually has left hip pain but not this bad. It's better today.
In the first week, sore at the injection site for 3 or so days,  The first night,  sinus headache, and sinus tenderness that persisted for 2-3 days with clear runny nose.  Day 5 and 6  nausea.  Day 7  -red , hot to the touch, firm reaction near injection site, increasing in size over next 3 days, now about 3 by 5 inch  irregular oval.  My doctor has prescribed an antibiotic.
Chills, Body Aches, Sore throat, Headache, Piloerection and sore throat
Patient was given 3rd dose of Moderna COVID-19 vaccine, lot #030L20A, on 02/21/2021.   Per medical records "Patient is a 91-year-old male with past medical history AFib, thrombocytopenia hypertension, TIA, Parkinson's, NPH status post shunt placement, CLL presenting with shortness of breath. Patient was encephalopathic upon initial encounter so unable to obtain history. He was intubated for airway protection hypoxia. Found to be positive for COVID 19. CT chest after being placed on mechanical ventilation showed large left-sided pneumothorax and pigtail catheter placed. Patient was hypotensive and required vasopressor support. Ceftriaxone was started for possible UTI. Decadron and remdesivir started for COVID. Blood cultures 2/4 are growing Gram-positive cocci in pairs and clusters, vancomycin started. Patient currently off pressors and off mechanical ventilation. 4 L oxygen requirement at this point in time. Transferred to step-down. Cardiology consulted for paroxysmal atrial fibrillation. Seen by speech therapy for oropharyngeal dysphagia. General surgery consulted for PEG tube placement and successful placed on 1/10. He developed worsening hypoxia on 1/12. Family decided on comfort care. He expired on 1/12. Time of death 10:47 AM."
The patient states that since the administration of flu vaccine, he has had persistent shoulder pain that radiates down his arm.  The patient states that even after >14 days, the pain is not changing.  He has emailed his PCP, but has not yet been seen by a medical professional regarding this issue.
Patient start experiencing diarrhea at midnight and it lasted all night on 10/11/19
allergic reaction; face was flushed.warm; face was flushed,warm; swelling; ears were red and hot; ears were red and hot; felt a bit off; This is a spontaneous report from a non-contactable Consumer.  A 72-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration (at the age of 72) on 20Feb2021 10:45 as single dose for covid-19 immunisation. Medical history included Follicular Non-Hodgins lymphoma, sleep apnoea syndrome, coronary artery disease, drug hypersensitivity to sulfur and penicillin, iodine contrast dye allergy. The patient's concomitant medications were not reported. No other vaccine was received in four weeks. No covid prior vaccination. No covid tested post vaccination. The patient experienced allergic reaction on 20Feb2021 10:45, face was flushed.warm  on 20Feb2021 10:45, swelling on 20Feb2021 10:45, ears were red and hot on 20Feb2021 10:45, felt a bit off on 20Feb2021 10:45. No treatment received. The events outcome was recovered ('by 11PM most of this resolved' as reported).    No follow-up attempts are possible; information about lot/batch number cannot be obtained
her left leg is uncoordinated; very weak; wobbly, She is "able to walk but have to think about it"; no pain but heavy; LOST STRENGTH; This is a spontaneous report from a contactable consumer via medical information team.   This consumer reported for a 29-year-old female patient (consumer's daughter) that she received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: solution for injection, Lot Number was not reported, Expiry date: Unknown), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced left leg is uncoordinated, very weak, wobbly, lost strength, no pain but heavy and able to walk but have to think about it. Patient has an appointment to see the doctor, but caller wanted to know if that was been reported. Th outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.